Emerging treatments in the management of psoriasis: biological targeting with ustekinumab
Marina Papoutsaki, Antonio Costanzo, Sergio ChimentiDepartment of Dermatology, University of Rome, “Tor vergata”, Rome, ItalyAbstract: Psoriasis is a chronic, genetically determined, immune-mediated, inflammatory skin disease affecting approximately 2% to 3% of Caucasian populati...
Saved in:
Main Authors: | Marina Papoutsaki (Author), Antonio Costanzo (Author), Sergio Chimenti (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ustekinumab Treatment of Erythrodermic Psoriasis Occurring after Physical Stress: A Report of Two Cases
by: Rosita Saraceno, et al.
Published: (2013) -
Thyrotoxicosis Associated with Ustekinumab Treatment for Psoriasis
by: Bayanne Olabi, et al.
Published: (2020) -
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumab
by: Ignacio Garcia-Valladares, et al.
Published: (2011) -
Peritoneal tuberculosis in the setting of ustekinumab treatment for psoriasis
by: Maeve Lynch, MD, MBBChBAO, et al.
Published: (2017) -
Ustekinumab: differential use in psoriasis
by: Uhlenhake EE, et al.
Published: (2011)